In a dizzying reversal, Biogen announced today that it would seek approval from the U.S. Food and Drug Administration (FDA) to begin marketing its…
Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD, showing the drug is as safe as the placebo with improvements…
Journalist and Alzheimer’s advocate Phil Gutis, who is living with early onset Alzheimer’s, shares some wisdom this Giving Tuesday. Another Thanksgiving has come and…
Since Terrie Montgomery was diagnosed with early-onset Alzheimer’s in 2015, she’s been an advocate for her own health — and the health of others….
In Phase 3 trials, Roche’s experimental Alzheimer’s drug gantenerumab has failed to meet its objectives for slowing cognitive decline. Most Alzheimer’s treatments on the market…
One of Alzheimer’s disease’s key players, beta-amyloid presents a complex picture. If you or a loved one is going through the diagnostic process for…
Reporter Phil Gutis is living with Alzheimer’s. So is his dog, Bea. One day, the same approach to treatment might help them both. Sometimes…